NO944524L - Anvendelse av (E)-2-(p-fluorfenetyl)-3-fluorallylamin ved behandling av Alzheimers sykdom - Google Patents

Anvendelse av (E)-2-(p-fluorfenetyl)-3-fluorallylamin ved behandling av Alzheimers sykdom

Info

Publication number
NO944524L
NO944524L NO944524A NO944524A NO944524L NO 944524 L NO944524 L NO 944524L NO 944524 A NO944524 A NO 944524A NO 944524 A NO944524 A NO 944524A NO 944524 L NO944524 L NO 944524L
Authority
NO
Norway
Prior art keywords
fluoroallylamine
fluorophenethyl
alzheimer
disease
treatment
Prior art date
Application number
NO944524A
Other languages
English (en)
Norwegian (no)
Other versions
NO944524D0 (no
Inventor
Ian A Mcdonald
Michael G Palfreyman
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO944524D0 publication Critical patent/NO944524D0/no
Publication of NO944524L publication Critical patent/NO944524L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO944524A 1992-05-27 1994-11-25 Anvendelse av (E)-2-(p-fluorfenetyl)-3-fluorallylamin ved behandling av Alzheimers sykdom NO944524L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88867192A 1992-05-27 1992-05-27
PCT/US1993/003522 WO1993024120A1 (en) 1992-05-27 1993-04-14 USE OF (E)-2-(p-FLUOROPHENETHYL)-3-FLUOROALLYLAMINE IN THE TREATEMENT OF ALZHEIMER'S DISEASE

Publications (2)

Publication Number Publication Date
NO944524D0 NO944524D0 (no) 1994-11-25
NO944524L true NO944524L (no) 1994-11-25

Family

ID=25393634

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944524A NO944524L (no) 1992-05-27 1994-11-25 Anvendelse av (E)-2-(p-fluorfenetyl)-3-fluorallylamin ved behandling av Alzheimers sykdom

Country Status (15)

Country Link
EP (1) EP0642338B1 (de)
JP (1) JPH07507299A (de)
KR (1) KR950701518A (de)
AT (1) ATE147978T1 (de)
AU (1) AU672401B2 (de)
CA (1) CA2135752C (de)
DE (1) DE69307702T2 (de)
DK (1) DK0642338T3 (de)
ES (1) ES2101311T3 (de)
GR (1) GR3022608T3 (de)
HU (1) HUT72316A (de)
MX (1) MX9303074A (de)
NO (1) NO944524L (de)
WO (1) WO1993024120A1 (de)
ZA (1) ZA933567B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1131390A (zh) * 1993-09-24 1996-09-18 默里尔药物公司 治疗早老性痴呆的含(e)-2-(对氟苯乙基)-3-氟烯丙胺的膏药
US5599986A (en) * 1994-09-29 1997-02-04 Hoechst Marion Roussel Inc. Process for the preparation of alkali metal salts of diformylamide
US5488188A (en) * 1994-09-29 1996-01-30 Merrell Dow Pharmaceuticals Inc. Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, novel processes for preparing an intermediate thereof, and novel intermediates thereof
US20070293548A1 (en) * 2006-03-31 2007-12-20 Wang Eric Y Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
EP1870097A1 (de) * 2006-06-15 2007-12-26 Newron Pharmaceuticals S.p.A. Alpha-aminoamidederivate zur Behandlung von kognitiven Störungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA884183B (en) * 1987-06-16 1989-02-22 Merrell Dow Pharma (e)-2-(p-fluorophenethyl)-3-fluoroallylamine

Also Published As

Publication number Publication date
CA2135752C (en) 1998-07-14
WO1993024120A1 (en) 1993-12-09
NO944524D0 (no) 1994-11-25
MX9303074A (es) 1994-01-31
DE69307702D1 (de) 1997-03-06
HUT72316A (en) 1996-04-29
ZA933567B (en) 1993-12-13
EP0642338B1 (de) 1997-01-22
AU672401B2 (en) 1996-10-03
HU9403384D0 (en) 1995-02-28
GR3022608T3 (en) 1997-05-31
KR950701518A (ko) 1995-04-28
EP0642338A1 (de) 1995-03-15
CA2135752A1 (en) 1993-12-09
JPH07507299A (ja) 1995-08-10
ATE147978T1 (de) 1997-02-15
AU3978293A (en) 1993-12-30
DK0642338T3 (da) 1997-02-10
ES2101311T3 (es) 1997-07-01
DE69307702T2 (de) 1997-05-28

Similar Documents

Publication Publication Date Title
EP0735870A4 (de) Verwendung von phospholipase-a2-inhibitoren zur behandlung der alzheimer-krankheit
NO981911D0 (no) Anvendelse av rhodaninderivater for fremstilling av et medikament for behandling av Alzheimer's sykdom
ES2127819T3 (es) Tratamiento de la degeneracion macular.
ATE241365T1 (de) Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
GB2285219A (en) Use of norastemizole for the treatment of allergic disorders
ES2136167T3 (es) Composiciones de idebenona para tratar la enfermedad de alzheimer.
NO20000771D0 (no) Anvendelse av fankinon for behandling av Alzheimers sykdom
IL117695A0 (en) Pharmaceutical agents for the treatment of alzheimer's disease
NO944524L (no) Anvendelse av (E)-2-(p-fluorfenetyl)-3-fluorallylamin ved behandling av Alzheimers sykdom
RU94011321A (ru) Способ профилактики и лечения заболеваний кожи
NO961180L (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
NO953072D0 (no) Anvendelse av inhibitorer av ornitinaminotransferase for fremstilling av et medikament for behandling av Alzheimers sykdom
DE69800906T2 (de) Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie
DK8893D0 (da) Medicament for treatment or prevention of disease
KR930703003A (ko) 피부질환치료용 제약 조성물

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application